BBHC
PAHC icon

Brown Brothers Harriman & Co’s Phibro Animal Health PAHC Stock Holding History

Brown Brothers Harriman & Co’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-290
Closed -$4K – 1442
2022
Q3 		$4K Buy
290
+235
+427% +$4.06K ﹤0.01% 1343
2022
Q2 		$1K Buy
+55
New +$1.04K ﹤0.01% 1280

Other funds holding PAHC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
SGCIA
Smith Graham & Co Investment Advisors Houston, Texas $868M AUM 24.69% 1-Year Est. Return

Brown Brothers Harriman & Co's PAHC Position: Q4 2022 in Review

Brown Brothers Harriman & Co sold out of Phibro Animal Health (PAHC) in Q4 2022, closing a stake of 290 shares — an estimated $4K sold.

Brown Brothers Harriman & Co first reported a position in PAHC in Q2 2022 and held it in 2 quarters. The position peaked at $4K in Q3 2022. 132 funds tracked by Wall St. Rank hold PAHC as of Q4 2022.

  • Brown Brothers Harriman & Co reported no remaining Phibro Animal Health position as of Q4 2022 after selling out during the quarter.
  • Brown Brothers Harriman & Co sold 290 Phibro Animal Health shares in Q4 2022, an estimated $4K.
  • Brown Brothers Harriman & Co first reported a position in Phibro Animal Health in Q2 2022 and held it in 2 quarters.
  • Brown Brothers Harriman & Co's Phibro Animal Health position peaked at $4K in Q3 2022.
  • 132 funds tracked by Wall St. Rank held Phibro Animal Health as of Q4 2022.

Based on Brown Brothers Harriman & Co's 13F filing for Q4 2022, filed 9 Feb 2023.